Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

INTRAMEDIC A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   2.5% 0.8% 1.0% 1.1% 0.6% 0.6% 9.5% 9.5%   Credit score (0-100)   64 94 86 84 96 97 26 26   Credit rating   BBB AA A A AA AA BB BB   Credit limit (kDKK)   0.1 1,447.8 1,469.1 1,223.9 2,169.1 1,621.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   17,363 15,156 21,553 22,212 14,358 15,274 0.0 0.0   EBITDA   9,292 6,946 13,123 13,347 5,498 5,658 0.0 0.0   EBIT   9,292 6,937 13,095 13,320 5,465 5,613 0.0 0.0   Pre-tax profit (PTP)   9,338.2 7,057.0 13,416.2 13,413.8 5,576.4 5,969.1 0.0 0.0   Net earnings   7,277.5 5,498.4 10,463.4 10,462.2 4,348.1 4,646.0 0.0 0.0   Pre-tax profit without non-rec. items   9,338 7,057 13,416 13,414 5,576 5,969 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 129 102 74.0 126 81.2 0.0 0.0   Shareholders equity total   10,564 9,062 14,026 14,488 13,836 8,482 2,882 2,882   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 847 0.0 0.0   Balance sheet total (assets)   22,434 16,007 25,396 30,005 23,997 19,586 2,882 2,882   Net Debt   -2,228 -2,734 -8,959 -5,689 -7,585 -4,487 -2,882 -2,882     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   17,363 15,156 21,553 22,212 14,358 15,274 0.0 0.0   Gross profit growth   6.7% -12.7% 42.2% 3.1% -35.4% 6.4% -100.0% 0.0%   Employees   11 12 13 13 13 14 0 0   Employee growth %   -8.3% 9.1% 8.3% 0.0% 0.0% 7.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   22,434 16,007 25,396 30,005 23,997 19,586 2,882 2,882   Balance sheet change%   48.9% -28.6% 58.7% 18.1% -20.0% -18.4% -85.3% 0.0%   Added value   9,292.3 6,946.2 13,122.5 13,347.3 5,492.7 5,657.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 120 -55 -55 19 -89 -81 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   53.5% 45.8% 60.8% 60.0% 38.1% 36.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   50.7% 37.4% 65.1% 49.1% 21.0% 27.8% 0.0% 0.0%   ROI %   100.8% 71.3% 114.1% 95.4% 40.0% 52.4% 0.0% 0.0%   ROE %   77.2% 56.0% 90.6% 73.4% 30.7% 41.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   49.3% 61.8% 58.6% 48.3% 57.7% 43.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -24.0% -39.4% -68.3% -42.6% -138.0% -79.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 10.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 23.2% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   1.9 2.8 2.4 2.1 2.3 1.6 0.0 0.0   Current Ratio   1.9 2.5 2.2 2.4 2.7 2.0 0.0 0.0   Cash and cash equivalent   2,228.3 2,733.6 8,958.7 5,689.5 7,584.6 5,334.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   10,563.8 9,454.7 13,827.4 17,268.1 14,829.7 9,481.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   845 579 1,009 1,027 423 404 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   845 579 1,009 1,027 423 404 0 0   EBIT / employee   845 578 1,007 1,025 420 401 0 0   Net earnings / employee   662 458 805 805 334 332 0 0